ConductScience.org, home

Paper449689

Availability of apolipoprotein CII in relation to the maximal removal capacity for an infused triglyceride emulsion in man.

Erkelens DW and 2 others. Metabolism, 1979. Cited by 49 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Availability of apolipoprotein CII in relation to the maximal removal capacity for an infused triglyceride emulsion in man. Papers, record 449689. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/449689

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Availability of apolipoprotein CII in relation to the maximal removal capacity for an infused triglyceride emulsion in man.
PubMed
Journal
Metabolism
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
2.19
iCite
Revised in PubMed
2019-07-25
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Erkelens DWD W
2Brunzell JDJ D
3Bierman ELE L

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ApolipoproteinsMajor topic
HyperlipidemiasMajor topic
TriglyceridesMajor topic
Adult
Aged
Binding, Competitive
Cholesterol
Electrophoresis, Polyacrylamide Gel
Female
Humans
Infusions, Parenteral
Kinetics
Male
Middle Aged

Source PubMed

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
34,986,301The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE-/-FXR-/- Mice.Endocrinol Metab (Seoul)2021https://conductscience.org/library/papers/34986301PubMed
33,769,561Individualization of the infusion rate of a soybean oil-based intravenous lipid emulsion for inpatients, based on baseline triglyceride concentrations: A population pharmacokinetic approach.JPEN J Parenter Enteral Nutr2022https://conductscience.org/library/papers/33769561PubMed
11,592,733Incubation of lipid emulsions with plasma lipoproteins modifies the fluidity of each particle.Lipids2001https://conductscience.org/library/papers/11592733PubMed
7,642,268Effect of hypertriglyceridemia on endotoxin responsiveness in humans.Infect Immun1995https://conductscience.org/library/papers/7642268PubMed
6,122,483Adrenergic mechanisms in control of plasma lipid concentrations.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6122483PubMed
2,692,008Apolipoproteins in lipid transport, an impressionist view.Postgrad Med J1989https://conductscience.org/library/papers/2692008PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
APOC2344PubTator's text mininghttps://conductscience.org/library/genes/344

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/449689

GET https://conductscience.org/api/papers/v1/449689/authors